Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction.
Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction. Immunity. 2021 Feb 09; 54(2):388.